Carl Fuller
About Carl Fuller
Carl W. Fuller's Professional Title
Carl W. Fuller is the Head of the Roswell Innovation Lab. In this role, he oversees pioneering research and development efforts within the lab, contributing to advancements in biotechnological tools focused on genomics.
Carl W. Fuller's Experience with DNA Polymerases, RNA Polymerases, and Reverse Transcriptases
With over 30 years of experience, Carl W. Fuller has specialized in the study and application of DNA polymerases, RNA polymerases, and reverse transcriptases. His extensive background in these enzymes has been essential in developing advanced sequencing technologies and biotechnological innovations.
Carl W. Fuller's Corporate Involvements
Carl W. Fuller has significantly contributed to the development of complete sequencing systems in the biotech industry. He played a key role in the creation of the capillary electrophoresis system at Molecular Dynamics/Amersham, the SOLiD sequencing system at Applied Biosystems, and chip-based sequencers at Genia (now part of Roche) and Ion Torrent.
Carl W. Fuller's Executive Roles
Carl W. Fuller has held senior and executive-level positions at several renowned biotechnology firms. His leadership experience includes roles at Singular Genomics, Genia Technologies (now Roche), Life Technologies, GE Healthcare, and Amersham Biosciences. His roles in these companies have involved directing significant advancements in genomic technologies.
Carl W. Fuller's Patents
Carl W. Fuller has an impressive portfolio of over 70 issued patents and patent applications. These patents reflect his contributions to innovations in genomic sequencing and related technologies, highlighting his role in advancing the field of biotechnology.